[breadcrumb_custom]

TC BioPharm (Holdings) plc ADR Inc. (TCBP) Price Performance: The Role of Supply and Demand

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -65.30% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -90.82%. Over the past 30 days, the price of TCBP has leaped by -50.89%. And in the last five days, it has surged by 2.80%.

TC BioPharm (Holdings) plc ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $155.40 on 02/15/23 and the lowest value was $0.85 on 02/05/24.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

52-week price history of TCBP Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. TC BioPharm (Holdings) plc ADR’s current trading price is -99.29% away from its 52-week high, while its distance from the 52-week low is 29.40%. The stock’s price range during this period has varied between$0.85 and $155.40. The TC BioPharm (Holdings) plc ADR’s shares, which operate in the Healthcare, saw a trading volume of around 1.05 million for the day, a figure considerably higher than their average daily volume of 0.3 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

TC BioPharm (Holdings) plc ADR (TCBP) has experienced a quarterly decline of -89.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 0.75M and boasts a workforce of 77 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.7814, with a change in price of -8.3040. Similarly, TC BioPharm (Holdings) plc ADR recorded 209,049 in trading volume during the last 100 days, posting a change of -88.30%.

TCBP’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TCBP stands at 1.16. Similarly, the long-term debt-to-equity ratio is also 0.83.

TCBP Stock Stochastic Average

As of today, TC BioPharm (Holdings) plc ADR’s raw stochastic average for the last 50 days stands at 3.02%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 12.31%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 7.53% and 4.82%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts